| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
1992-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_403a52462e8943ad47583f125bc4fbef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e20b8382fad47912605be1b36b0faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415b75e932c3d53ad284d7b9346b3072 |
| publicationDate |
1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0505749-A2 |
| titleOfInvention |
Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| abstract |
Monoclonal antibodies are produced that bind specifically to IL-1 activated endothelial cells. Antigens to which the monoclonal antibodies specifically bind are identified. The monoclonal antibodies and antigens are useful in a medicament and method for treating inflammatory responses associated with activated endothelial cells, and for diagnosing inflammatory responses. A cDNA sequence that codes for antigen 1E7/2G7 and the CD4⁺ ELAM ligand are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7449186-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5610148-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0669988-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6123915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0669988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5728802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5648458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5643873-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5786322-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5629287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5827670-A |
| priorityDate |
1991-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |